rjac/clinicaltrials.gov-summary_and_eligibility huggingface dataset:
Effect of Hypopressive Exercises on Postpartum Backache and Functional Disability
Status: Not yet recruiting

The purpose of this study was to evaluate the effectiveness of hypopressive exercise in postpartum females with abnormal hyperlordosis and back pain.

Eligibility:
- EligibilityCriteria: Inclusion Criteria:  Participants must have a healthy pregnancy Normal vaginal birth LBP that existed 24 weeks after giving birth Functional limitations in daily activities. Participants' age from 20 to 35 years  Exclusion Criteria:  No more than two prior pregnancies BMI of less than 25 kg/m2 to participate. Women who were under pharmacological or psychological treatment, had pelvic tumors, lumbar disk herniation, heart disease, hypertension, lumbar spine tumors, chronic uterine prolapse, chronic pelvic pain, lumbar spondylosis, or lumbar spondylolisthesis. - HealthyVolunteers: Accepts Healthy Volunteers - Gender: Female - MinimumAge: 20 Years - MaximumAge: 35 Years - StdAgeList: Adult
Feasibility of Optimizing Organized Cervical Cancer Screening by Urine Self-sampling
Status: Recruiting

This project addresses the issue of promoting organized cervical cancer screening (CCS) from the perspective of the use of urine self-sampling (USS). Via a prospective and monocentric study, the present study aims to evaluate the acceptability of women to collect a urine self-sample and to respond to a questionnaire on their feelings about this screening method.

Eligibility:
- EligibilityCriteria: Inclusion Criteria:  Women aged 31 to 49 Coming to the Bordeaux University Hospital for a gynecological consultation in order to have a cervical swab (PCC) for screening or follow-up. Patient affiliated to or benefiting from a social security system Non-objection to study participation  Exclusion Criteria:  Patient unable to speak French and/or illiterate Patient under legal protection - HealthyVolunteers: No - Gender: Female - MinimumAge: 18 Years - MaximumAge: 49 Years - StdAgeList: Adult
Modulating Energy Density in Time-Restricted Eating
Status: Not yet recruiting

The goal of this randomized controlled trial is to test the effect of time-restricted eating (14-hour fast, 10-hour eating window) of a low-energy dense diet (reduced calories per gram of food) in older adults with obesity and insulin resistance. The study aims to determine if modulating the energy density of the diet reduces:

Insulin resistance and
Body weight.

Researchers will compare the groups:

Following time-restricted eating and given a diet reduced in energy density or
Following time-restricted eating and given a diet typically consumed in this population

Eligibility:
- EligibilityCriteria: Inclusion Criteria:  Body mass index (BMI) ≥ 30kg/m2. Mini-Mental State Examination (MMSE) > 25 Geriatric Depression Scale-15 (GDS-15) < 9 Homeostatic model assessment of insulin resistance (HOMA-IR) ≥ 3.  Exclusion Criteria:  Diagnosis of Type 2 diabetes received more than five years ago Diagnosis of type 1 diabetes Evidence of clinically significant renal dysfunction or disease History of malignancy during the past five years Being treated with systemic steroids, olanzapine, or clozapine Being treated with prescription medications for obesity Being treated with thiazolidinediones, glucagon-like-receptor agonists, Dipeptidyl Peptidase IV inhibitors, and insulin Weight change > 3 kg in the preceding three months Any disease or condition that precludes testing of the study outcomes or makes it unsafe to consume the foods being tested in the study, or subjects are otherwise deemed to be unsuitable for participation in the study (determined by the investigative team) - HealthyVolunteers: No - Gender: All - MinimumAge: 50 Years - MaximumAge: 75 Years - StdAgeList: Adult, Older Adult
Method VALIDation and Evaluation of Non-radioactive Methods to Measure Glomerular Filtration Rate
Status: Not yet recruiting

This study is a single centre intervention study to compare two methods of determining the measured glomerular filtration rate (mGFR). Subjects who receive radioactively labeled iothalamate (125I) and hippuran (131I) within the framework of routine clinical care, will be co-administered iohexol. The primary trial endpoint is the mGFR when administered 125I-iothalamate and 131I-hippuran versus iohexol. By determining the mGFR using both iohexol and iothalamate in the same patients, a direct comparison of the two methods can be made in terms of their accuracy and precision. This makes it possible to determine the potential use of the non-radioactive measurement method as an alternative to the radioactive method and thus lower the overall radioactive burden for patients and personnel.

Eligibility:
- EligibilityCriteria: Inclusion Criteria:  Scheduled to undergo a kidney function measurement test as part of standard care. Written informed consent.  Exclusion Criteria:  History of hypersensitivity to iodinated contrast media or one of the excipients in the formulation of iohexol (trometamol, sodium calcium edetate, hydrochloric acid). Subjects with (suspected or known) thyrotoxicosis. Pregnant women and women of child-bearing potential who are not using reliable contraception. Patients who are unlikely to comply to the trial's procedure (non-compliance). - HealthyVolunteers: Accepts Healthy Volunteers - Gender: All - MinimumAge: 18 Years - StdAgeList: Adult, Older Adult